Barrett Esophagus clinical trials
39 active trials name this condition. Describe your situation to see which ones you may be eligible for.
By location
- Surveillance vs. Endoscopic Therapy for Barrett's Esophagus With Low-grade Dysplasia
- Itraconazole in Combination With Ablation for the Prevention of Esophageal Cancer in Patients With High-risk Barrett's Esophagus
- Multi-Site Detection of Barrett's Esophagus in Patients Without Chronic GERD Symptoms
- Obeticholic Acid for Prevention in Barrett's Esophagus
- Navicam for Detection of Barrett's Esophagus
- Nonendoscopic Screening for Barrett's Esophagus in Veterans Without Chronic Reflux
- Assessment of a Minimally Invasive Collection Device for Molecular Analysis of Esophageal Samples
- Minimally Invasive Molecular Approaches for the Diagnosis of Barrett's Esophagus and Esophageal Adenocarcinoma
- Seattle Biopsy Protocol Versus Wide-Area Transepithelial Sampling in Patients With Barrett's Esophagus Undergoing Surveillance
- Mechanisms Preventing Pharyngeal Reflux
- Impact of RFA on Esophageal Distensibility and Mucosal Impedance
- Non-Endoscopic Detection of Barrett's Esophagus Using Methylation Biomarkers on EndoSign® Cell Collection Device Samples
- Patient Preferences for Barrett's Esophagus and Esophageal Cancer Screening Tests
- Longitudinal Oral Microbiome Sampling for BE
- TREAT-BE Study (Treatment With Resection and Endoscopic Ablation Techniques for Barrett's Esophagus)
- Barrett's Esophagus Related Neoplasia (BERN) Project
- Genetic Determinants of Barrett's Esophagus and Esophageal Adenocarcinoma
- Barrett's Esophagitis in Anorexia Nervosa Binge/Purge Subtype
- Endoscopic Submucosal Dissection (ESD)
- Clinical Utility of WATS3D: A 5-Year Prospective Study
- EsophaCap for the Detection of Early Esophageal Carcinoma
- Progression of Gastroesophageal Reflux Disease and Barrett's Esophagus and the Creation of a Barrett's Registry
- InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer
- Esophageal Cancer Risk Registry
- Pilot Study for OCT Guided In Vivo Laser Capture Microdissection for Assessing the Prognosis of Barrett's Esophagus
- Pilot Study for TCE Imaging of the Esophagus Using an OFDI Capsule With a Compact Imaging System
- Enhancing Screening Practices for BE
- Minimally Invasive Approaches for the Diagnosis of Barrett's Esophagus and Esophageal Cancer, SOS5C Trial
- Evaluation of Tethered Capsule Endomicroscopy as a Screening Tool for Barrett's Esophagus in the Primary Care Setting
- Outcomes After Transoral Incisionless Fundoplication (TIF) Following Successful Endoscopic Ablation for Barrett's Esophagus
- The Effect of Ablation Therapy on Barrett's Esophagus
- Minimally Invasive Molecular Approaches for the Detection of Barrett's Esophagus- High Grade Dysplasia and Esophageal Adenocarcinoma
- Study to Evaluate EnteroTracker® as a Sampling Method to Screen for Barrett's Esophagus/Esophageal Cancer
- Biomarkers of Airway Disease, Barrett's and Underdiagnosed Reflux Noninvasively (BADBURN)
- The Johns Hopkins Heartburn Center Registry
- Outcome Analysis of POEM and Endoluminal Therapies
- University of North Carolina (UNC) Barrett's Esophagus and Esophageal Cancer Biorepository
- Wide-Area Transepithelial Sampling in Endoscopic Eradication Therapy for Barrett's Esophagus
- Changes Associated With H. Pylori and Gastric Carcinogenesis
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Barrett Esophagus” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.